Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Oncology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
Cns
International Catalog
INFECTIOUS DISEASES - TORCH
LIAISON® HSV-1 Type Specific IgG |
310830 |
Intended use |
For the qualitative determination of IgG antibodies to Herpes simplex 1 virus |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2 step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum |
LIAISON® Toxo IgG II |
310780 |
Intended use |
For the quantitative determination of IgG antibodies to Toxoplasma gondii. |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included (WHO 2nd IS 1980) |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® Toxo IgM |
310710 |
Intended use |
For the quantitative determination (reverse) of IgM antibodies to Toxoplasma gondii. |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® Toxo IgG Avidity II |
310790 |
Intended use |
For the determination of antigen-binding avidity of IgG antibodies to Toxoplasma gondii |
Material provided |
Reagent integral for 25 determinations. Diluent included |
Method |
3 step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
30 min |
Sample type |
Serum/Plasma |
LIAISON® Rubella IgG |
310720 |
Intended use |
For the quantitative determination of IgG antibodies to Rubella virus. |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included (RUB-1-94 NIBSC 1st IS 1997) |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® Rubella IgM |
310730 |
Intended use |
For the quantitative determination (antbody capturei) of IgM antibodies to Rubella virus. |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
30 min |
Sample type |
Serum/Plasma |
LIAISON® CMV IgG |
310740 |
Intended use |
For the quantitative determination of IgG antibodies to human Cytomegalovirus. |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included (WHO IS 1995) |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® CMV IgM |
310750 |
Intended use |
For the quantitative determination of IgM antibodies to human Cytomegalovirus. |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
30 min |
Sample type |
Serum/Plasma |
LIAISON® CMV IgG Avidity |
310760 |
Intended use |
For the determination of antigen-binding avidity of IgG antibodies to human Cytomegalovirus. |
Material provided |
Reagent Integral for 25 determinations. Diluent included |
Method |
3-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
30 min |
Sample type |
Serum/Plasma |
LIAISON® HSV 1/2 IgG |
310800 |
Intended use |
For the qualitative determination of IgG antibodies to Herpes simplex 1 virus and Herpes simplex 2 virus |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2 step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® HSV 2 IgG |
310810 |
Intended use |
For the qualitative determination of IgG antibodies to Herpes simplex 2 virus |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2 step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® HSV 1/2 IgM |
310820 |
Intended use |
For the qualitative determination of IgM antibodies to Herpes simplex 1 virus and Herpes simplex 2 virus |
Material provided |
Reagent Integral for 100 determinations. Diluent included |
Method |
2 step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® Biotrin Parvovirus B19 IgG |
317000 / 50 tests |
Intended use |
For the qualitative detection of IgG antibodies against Parvovirus B19 |
Method |
CLIA (Indirect) |
Calibrators |
On-board, triplicate |
Incubations |
31 minutes |
Sample type |
Serum or plasma |
Sample size |
5 µL |


